Stellate Cell Contraction: Role, Regulation, and Potential Therapeutic Target

Clinics in Liver Disease

Volumn 12, Issue 4, 2008, Pages 791-803

  Soon Jr , Russell K ^a   Yee Jr , Hal F ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Contraction; Fibrosis; Hepatic stellate cell; Pericyte; Rho associated kinase; Sinusoid

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MYOSIN II; NITRIC OXIDE; RHO FACTOR; RHO KINASE INHIBITOR;

CALCIUM SIGNALING; CELL FUNCTION; DRUG DELIVERY SYSTEM; DRUG TARGETING; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE THERAPY; HUMAN; LIVER BLOOD FLOW; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER SINUSOID; NONHUMAN; PORTAL HYPERTENSION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; STELLATE CELL; WOUND HEALING;

ANIMALS; CONTRACTILE PROTEINS; ENDOTHELIN-1; EXTRACELLULAR MATRIX; HEPATIC STELLATE CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER CIRRHOSIS; MYOSIN TYPE II; NITRIC OXIDE; PORTAL SYSTEM; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION;

EID: 54549111222     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2008.07.004     Document Type: Review

References (99)

1. Schmitt-Graff A., Kruger S., Bochard F., et al. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 138 5 (1991) 1233-1242
2. Nouchi T., Tanaka Y., Tsukada T., et al. Appearance of alpha-smooth-muscle-actin-positive cells in hepatic fibrosis. Liver 11 2 (1991) 100-115
3. Yamaoka K., Nouchi T., Marumo F., et al. Alpha-smooth-muscle actin expression in normal and fibrotic human livers. Dig Dis Sci 38 8 (1993) 1473-1479
4. Enzan H., Himeno H., Iwamura S., et al. Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Arch 424 3 (1994) 249-256
5. Enzan H., Himeno H., Iwamura S., et al. Sequential changes in human Ito cells and their relation to postnecrotic liver fibrosis in massive and submassive hepatic necrosis. Virchows Arch 426 1 (1995) 95-101
6. Baroni G.S., Pastorelli A., Manzin A., et al. Hepatic stellate cell activation and liver fibrosis are associated with necroinflammatory injury and Th1-like response in chronic hepatitis C. Liver 19 3 (1999) 212-219
7. Pinzani M., Milani S., De Franco R., et al. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 110 2 (1996) 534-548
8. Yokomori H., Oda M., Yasogawa Y., et al. Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver. Am J Pathol 159 4 (2001) 1353-1362
9. Bataller R., Nicolas J.M., Gines P., et al. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. Gastroenterology 113 2 (1997) 615-624
10. Bataller R., Gines P., Nicolas J.M., et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118 6 (2000) 1149-1156
11. Hautekeete M.L., and Geerts A. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch 430 3 (1997) 195-207
12. Sims D.E. The pericyte-a review. Tissue Cell 18 2 (1986) 153-174
13. Sims D.E. Recent advances in pericyte biology-implications for health and disease. Can J Cardiol 7 10 (1991) 431-443
14. Pallone T.L., and Silldorff E.P. Pericyte regulation of renal medullary blood flow. Exp Nephrol 9 3 (2001) 165-170
15. Novo E., Cannito S., Zamara E., et al. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am J Pathol 170 6 (2007) 1942-1953
16. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 5309 (1997) 75-81
17. Nedelec B., Ghahary A., Scott P.G., et al. Control of wound contraction. Basic and clinical features. Hand Clin 16 2 (2000) 289-302
18. Darby I.A., and Hewitson T.D. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257 (2007) 143-179
19. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88 1 (2008) 125-172
20. Pinzani M., Failli P., Ruocco C., et al. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest 90 2 (1992) 642-646
21. Sakamoto M., Ueno T., Kin M., et al. Ito cell contraction in response to endothelin-1 and substance P. Hepatology 18 4 (1993) 978-983
22. Tao J., Mallat A., Gallois C., et al. Biological effects of C-type natriuretic peptide in human myofibroblastic hepatic stellate cells. J Biol Chem 274 34 (1999) 23761-23769
23. Bataller R., Gasull X., Gines P., et al. In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology 33 4 (2001) 956-962
24. Kawada N., Klein H., and Decker K. Eicosanoid-mediated contractility of hepatic stellate cells. Biochem J 285 Pt 2 (1992) 367-371
25. Kawada N., Tran-Thi T.A., Klein H., et al. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 213 2 (1993) 815-823
26. Kawada N., and Inoue M. Effect of adrenomedullin on hepatic pericytes (stellate cells) of the rat. FEBS Lett 356 1 (1994) 109-113
27. Kawada N., Kuroki T., Kobayashi K., et al. Action of endothelins on hepatic stellate cells. J Gastroenterol 30 6 (1995) 731-738
28. Housset C., Rockey D.C., and Bissell D.M. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci U S A 90 20 (1993) 9266-9270
29. Rockey D.C., Housset C.N., and Friedman S.L. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest 92 4 (1993) 1795-1804
30. Mashiba S., Mochida S., Ishikawa K., et al. Inhibition of hepatic stellate cell contraction during activation in vitro by vascular endothelial growth factor in association with upregulation of FLT tyrosine kinase receptor family, FLT-1. Biochem Biophys Res Commun 258 3 (1999) 674-678
31. Yanase M., Ikeda H., Matsui A., et al. Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. Biochem Biophys Res Commun 277 1 (2000) 72-78
32. Reynaert H., Vaeyens F., Qin H., et al. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 121 4 (2001) 915-930
33. Kharbanda K.K., Rogers II D.D., Wyatt T.A., et al. Transforming growth factor-beta induces contraction of activated hepatic stellate cells. J Hepatol 41 1 (2004) 60-66
34. Perri R.E., Langer D.A., Chatterjee S., et al. Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation. Am J Physiol Gastrointest Liver Physiol 290 3 (2006) G535-G542
35. Laleman W., Van Landeghem L., Severi T., et al. Both Ca2+-dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyperresponsiveness to methoxamine. Am J Physiol Gastrointest Liver Physiol 292 2 (2007) G556-G564
36. Zhang J.X., Pegoli Jr. W., and Clemens M.G. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 266 4 Pt 1 (1994) G624-G632
37. Bauer M., Paquette N.C., Zhang J.X., et al. Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat. Hepatology 22 5 (1995) 1565-1576
38. Suematsu M., Goda N., Sano T., et al. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest 96 5 (1995) 2431-2437
39. Vanheule E., Geerts A.M., Reynaert H., et al. Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy. Liver Int 28 1 (2008) 107-116
40. Thimgan M.S., and Yee Jr. H.F. Quantitation of rat hepatic stellate cell contraction: stellate cells' contribution to sinusoidal resistance. Am J Physiol 277 1 Pt 1 (1999) G137-G143
41. Saab S., Tam S.P., Tran B.N., et al. Myosin mediates contractile force generation by hepatic stellate cells in response to endothelin-1. J Biomed Sci 9 6 Pt 2 (2002) 607-612
42. 2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1. Am J Physiol Gastrointest Liver Physiol 290 1 (2006) G7-G13
43. Yanase M., Ikeda H., Ogata I., et al. Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line. Biochem Biophys Res Commun 305 2 (2003) 223-228
44. Moller S., Emmeluth C., and Henriksen J.H. Elevated circulating plasma endothelin-1 concentrations in cirrhosis. J Hepatol 19 2 (1993) 285-290
45. Alam I., Bass N.M., Bacchetti P., et al. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am J Gastroenterol 95 1 (2000) 199-203
46. Gandhi C.R., Sproat L.A., and Subbotin V.M. Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats. Life Sci 58 1 (1996) 55-62
47. Rockey D.C., Fouassier L., Chung J.J., et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology 27 2 (1998) 472-480
48. Tran-Thi T.A., Kawada N., and Decker K. Regulation of endothelin-1 action on the perfused rat liver. FEBS Lett 318 3 (1993) 353-357
49. Okumura S., Takei Y., Kawano S., et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 19 1 (1994) 155-161
50. Rockey D.C., and Weisiger R.A. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Hepatology 24 1 (1996) 233-240
51. Kaneda K., Ekataksin W., Sogawa M., et al. Endothelin-1-induced vasoconstriction causes a significant increase in portal pressure of rat liver: localized constrictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction. Hepatology 27 3 (1998) 735-747
52. De Gottardi A., Shaw S., Sagesser H., et al. Type A, but not type B, endothelin receptor antagonists significantly decrease portal pressure in portal hypertensive rats. J Hepatol 33 5 (2000) 733-737
53. Rockey D.C., and Chung J.J. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest 95 3 (1995) 1199-1206
54. Goda N., Suzuki K., Naito M., et al. Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation. J Clin Invest 101 3 (1998) 604-612
55. Wang X.E., Watanabe S., Oide H., et al. Hepatic stellate cell contraction is inhibited by lipo-prostaglandin E1 in vitro. J Gastroenterol Hepatol 13 Suppl (1998) S14-S18
56. Rockey D.C., and Chung J.J. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 114 2 (1998) 344-351
57. Sarela A.I., Mihaimeed F.M., Batten J.J., et al. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut 44 5 (1999) 749-753
58. Yu Q., Shao R., Qian H.S., et al. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. J Clin Invest 105 6 (2000) 741-748
59. Sakamoto M., Ueno T., Sugawara H., et al. Relaxing effect of interleukin-1 on rat cultured Ito cells. Hepatology 25 6 (1997) 1412-1417
60. Gasull X., Bataller R., Gines P., et al. Human myofibroblastic hepatic stellate cells express Ca(2+)-activated K(+) channels that modulate the effects of endothelin-1 and nitric oxide. J Hepatol 35 6 (2001) 739-748
61. Surks H.K., Mochizuki N., Kasai Y., et al. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science 286 5444 (1999) 1583-1587
62. Etter E.F., Eto M., Wardle R.L., et al. Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. J Biol Chem 276 37 (2001) 34681-34685
63. Nakamura K., Koga Y., Sakai H., et al. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ Res 101 7 (2007) 712-722
64. Laleman W., Van Landeghem L., Van der Elst I., et al. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats. Gastroenterology 132 2 (2007) 709-719
65. Racine-Samson L., Rockey D.C., and Bissell D.M. The role of alpha1beta1 integrin in wound contraction. A quantitative analysis of liver myofibroblasts in vivo and in primary culture. J Biol Chem 272 49 (1997) 30911-30917
66. Rockey D.C. New concepts in the pathogenesis of portal hypertension: hepatic wounding and stellate cell contractility. Clin Liver Dis 1 1 (1997) 13-29
67. Rockey D.C. Cellular pathophysiology of portal hypertension and prospects for management with gene therapy. Clin Liver Dis 5 3 (2001) 851-865
68. Somlyo A.P., and Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature 372 6503 (1994) 231-236
69. Somlyo A.P., and Somlyo A.V. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83 4 (2003) 1325-1358
70. Yee Jr. H.F. Rho directs activation-associated changes in rat hepatic stellate cell morphology via regulation of the actin cytoskeleton. Hepatology 28 3 (1998) 843-850
71. Kawada N., Seki S., Kuroki T., et al. ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. Biochem Biophys Res Commun 266 2 (1999) 296-300
72. Tangkijvanich P., Tam S.P., and Yee Jr. H.F. Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rho-kinase-mediated alterations in the acto-myosin cytoskeleton. Hepatology 33 1 (2001) 74-80
73. Melton A.C., and Yee H.F. Hepatic stellate cell protrusions couple platelet-derived growth factor-BB to chemotaxis. Hepatology 45 6 (2007) 1446-1453
74. Kato M., Iwamoto H., Higashi N., et al. Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells. J Hepatol 31 1 (1999) 91-99
75. 2+ and rho signaling pathways: two paths to hepatic stellate cell contraction. Hepatology 33 4 (2001) 1007-1008
76. Reynaert H., Thompson M.G., Thomas T., et al. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut 50 4 (2002) 571-581
77. Bataller R., Nicolas J.M., Ginees P., et al. Contraction of human hepatic stellate cells activated in culture: a role for voltage-operated calcium channels. J Hepatol 29 3 (1998) 398-408
78. Kolodney M.S., Thimgan M.S., Honda H.M., et al. Ca2+-independent myosin II phosphorylation and contraction in chicken embryo fibroblasts. J Physiol 515 Pt 1 (1999) 87-92
79. Parizi M., Howard E.W., and Tomasek J.J. Regulation of LPA-promoted myofibroblast contraction: role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Exp Cell Res 254 2 (2000) 210-220
80. Yee Jr. H.F., Melton A.C., and Tran B.N. RhoA/rho-associated kinase mediates fibroblast contractile force generation. Biochem Biophys Res Commun 280 5 (2001) 1340-1345
81. Blomhoff R., and Wake K. Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis. FASEB J 5 3 (1991) 271-277
82. Ekataksin W., and Kaneda K. Liver microvascular architecture: an insight into the pathophysiology of portal hypertension. Semin Liver Dis 19 4 (1999) 359-382
83. Oikawa H., Masuda T., Kawaguchi J., et al. Three-dimensional examination of hepatic stellate cells in rat liver and response to endothelin-1 using confocal laser scanning microscopy. J Gastroenterol Hepatol 17 8 (2002) 861-872
84. Wake K. Liver perivascular cells revealed by gold and silver impregnation methods and electron microscopy. In: Motta P. (Ed) (2001), Kluwer, Biopathology of the liver: an ultrastructural approach. Dordrecht (Netherlands) 23-26
85. Zhang J.X., Bauer M., and Clemens M.G. Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver. Am J Physiol 269 2 Pt 1 (1995) G269-G277
86. Tangkijvanich P., and Yee Jr. H.F. Cirrhosis-can we reverse hepatic fibrosis?. Eur J Surg Suppl 168 Suppl 587 (2002) 100-112
87. Murphy F., Arthur M., and Iredale J. Developing strategies for liver fibrosis treatment. Expert Opin Investig Drugs 11 11 (2002) 1575-1585
88. Rockey D.C. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis 10 3 (2006) 459-479
89. Friedman S.L., and Bansal M.B. Reversal of hepatic fibrosis - fact or fantasy?. Hepatology 43 2 Suppl 1 (2006) S82-S88
90. Zhou Q., Hennenberg M., Trebicka J., et al. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 55 9 (2006) 1296-1305
91. Kitamura K., Tada S., Nakamoto N., et al. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis. J Gastroenterol Hepatol 22 11 (2007) 2022-2033
92. Tada S., Iwamoto H., Nakamuta M., et al. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol 34 4 (2001) 529-536
93. Murata T., Arii S., Nakamura T., et al. Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. J Hepatol 35 4 (2001) 474-481
94. Murata T., Arii S., Mori A., et al. Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. J Surg Res 114 1 (2003) 64-71
95. Beljaars L., Molema G., Schuppan D., et al. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor. J Biol Chem 275 17 (2000) 12743-12751
96. Gonzalo T., Beljaars L., van de Bovenkamp M., et al. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells. J Pharmacol Exp Ther 321 3 (2007) 856-865
97. Kinoshita K., Iimuro Y., Fujimoto J., et al. Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis. Gut 56 3 (2007) 396-404
98. Schoemaker M.H., Rots M.G., Beljaars L., et al. PDGF-receptor beta-targeted adenovirus redirects gene transfer from hepatocytes to activated stellate cells. Mol Pharm 5 (2008) 399-406
99. Sato Y., Murase K., Kato J., et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 26 (2008) 431-442